Corbo, Christian .
HRN: 23-01-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/14/2023
05/21/2023
IV
500mg
Q8
PCAP
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes